-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Zanidatamab in Adenocarcinoma Of The Gastroesophageal Junction
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Zanidatamab in Adenocarcinoma Of The Gastroesophageal Junction Drug Details: Zanidatamab is under development for the...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Ketamine in Pathological Gambling
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Ketamine in Pathological Gambling report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.Ketamine in Pathological GamblingDrug Details:Ketamine is under development for the treatment of alcohol...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Ondansetron Hydrochloride CR in Diarrhea
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Ondansetron Hydrochloride CR in Diarrhea Drug Details: Ondansetron hydrochloride (RHB-102, Bekinda) is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – JNJ-8780 in B-Cell Non-Hodgkin Lymphoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - JNJ-8780 in B-Cell Non-Hodgkin Lymphoma report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. JNJ-8780 in B-Cell Non-Hodgkin Lymphoma Drug Details: JNJ-8780 is under development...
-
Product Insights
Cardiac Rhythm Management Devices Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies
Cardiac Rhythm Management Devices Pipeline Market Report Overview Cardiac Rhythm Management (CRM) devices are those devices which are used to restore the natural synchronized pumping rhythm of the heart. These include Pacemakers, Cardiac Resynchronisation Therapy (CRT), Implantable Loop Recorders and Implantable Cardioverter Defibrillators (ICD). These devices are used for the treatment of congestive heart failure. The Cardiac Rhythm Management Devices pipeline market research report provides comprehensive information about the Cardiac Rhythm Management Devices pipeline products with comparative analysis of the...
-
Product Insights
NewXtremity & Spinal Solutions Ltd Pipeline Insight and Competitive Landscape, 2023
Empower your strategies with our Xtremity & Spinal Solutions Ltd Pipeline Insight and Competitive Landscape, 2023 report and make more profitable business decisions. Xtremity & Spinal Solutions Ltd (Xtremity & Spinal ), formerly Implants International Ltd, is a medical device company that manufactures, designs, and develops orthopedic implants, bio-engineering, and other products for the healthcare sector. The company’s products include revision systems, hip stems, hip stem ancillaries, acetabular systems, femoral heads, and acetabular poly cups, among others. It also provides...
-
Product Insights
NewRegeneron Pharmaceuticals Inc Pipeline Insight and Competitive Landscape, 2023
Empower your strategies with our Regeneron Pharmaceuticals Inc Pipeline Insight and Competitive Landscape, 2023 report and make more profitable business decisions. Regeneron Pharmaceuticals Inc (Regeneron) is engaged in discovering, developing, manufacturing, and marketing medicines for the treatment of serious medical conditions. Its products are focused on helping patients suffering from cancer, allergic and inflammatory diseases, eye diseases, metabolic and cardiovascular diseases, infectious diseases, neuromuscular diseases, hematologic conditions, pain, and rare diseases. It develops products using its Trap and VelociSuite technology...
-
Product Insights
Lyme Disease Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Lyme disease is a bacterial infection transmitted by a tick. Lyme disease is caused by the bacterium Borrelia burgdorferi. Symptoms include rash, fever, chills, fatigue, body aches and headache. Risk factors include age, gender and geographic locations. The Lyme Disease - Drugs In Development research report provides a comprehensive overview on the therapeutics under development for Lyme Disease, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report ...
-
Sector Analysis
Turkey – Healthcare (Pharma and Medical Devices) Market Analysis, Regulatory, Reimbursement and Competitive Landscape
The pharmaceutical market size in Turkey was valued at $7.5 billion in 2020. The market is expected to grow further at a CAGR of less than 1% from 2021-2027. The Turkey healthcare market is potentially attractive for multinational firms seeking to invest in joint ventures and other types of mutually beneficial collaborations with their Turkish counterparts. Turkey's favorable environment for pharmaceutical investments is driven by strong government support, manufacturing and R&D incentives, increasing per capita income, an expanding middle-class population,...
-
Product Insights
Positron Emission Tomography (PET) Systems Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2021
A Positron Emission Tomography (PET) scan is an imaging test that helps reveal how your tissues and organs are functioning. A PET scan uses a radioactive drug (tracer) to show this activity. GlobalData's Medical Devices sector report, “Positron Emission Tomography (PET) Systems - Medical Devices Pipeline Product Landscape, 2021" provides comprehensive information about the Positron Emission Tomography (PET) Systems pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are...